Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP308476.RAbeHGZF9Ivp1_ZZP5_CctUf20FTo9nfRCdQ7AUQX_T74130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP308476.RAbeHGZF9Ivp1_ZZP5_CctUf20FTo9nfRCdQ7AUQX_T74130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP308476.RAbeHGZF9Ivp1_ZZP5_CctUf20FTo9nfRCdQ7AUQX_T74130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP308476.RAbeHGZF9Ivp1_ZZP5_CctUf20FTo9nfRCdQ7AUQX_T74130_provenance.
- befree-20150227 importedOn "2015-02-27" NP308476.RAbeHGZF9Ivp1_ZZP5_CctUf20FTo9nfRCdQ7AUQX_T74130_provenance.
- NP308476.RAbeHGZF9Ivp1_ZZP5_CctUf20FTo9nfRCdQ7AUQX_T74130_assertion wasGeneratedBy ECO_0000203 NP308476.RAbeHGZF9Ivp1_ZZP5_CctUf20FTo9nfRCdQ7AUQX_T74130_provenance.
- NP308476.RAbeHGZF9Ivp1_ZZP5_CctUf20FTo9nfRCdQ7AUQX_T74130_assertion wasDerivedFrom befree-20150227 NP308476.RAbeHGZF9Ivp1_ZZP5_CctUf20FTo9nfRCdQ7AUQX_T74130_provenance.
- NP308476.RAbeHGZF9Ivp1_ZZP5_CctUf20FTo9nfRCdQ7AUQX_T74130_assertion SIO_000772 24577808 NP308476.RAbeHGZF9Ivp1_ZZP5_CctUf20FTo9nfRCdQ7AUQX_T74130_provenance.
- NP308476.RAbeHGZF9Ivp1_ZZP5_CctUf20FTo9nfRCdQ7AUQX_T74130_assertion evidence source_evidence_literature NP308476.RAbeHGZF9Ivp1_ZZP5_CctUf20FTo9nfRCdQ7AUQX_T74130_provenance.
- NP308476.RAbeHGZF9Ivp1_ZZP5_CctUf20FTo9nfRCdQ7AUQX_T74130_assertion description "[Although clinical trials have been performed with anti-IL-5 (mepolizumab) and anti-CD52 (alemtuzumab) antibodies, their therapeutic role in primary eosinophilic diseases and HES has yet to be established.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP308476.RAbeHGZF9Ivp1_ZZP5_CctUf20FTo9nfRCdQ7AUQX_T74130_provenance.